PTEN and chronic myelogenous leukemia, BCR-ABL1 positive: In a study conducted by Panuzzo et al., it is shown that tumor inhibitor PTEN serves a key role in the pathogenesis of chronic phase CML by non genomic loss of function mechanisms19.